P16

By Targets:	Akt (1) AMPK (1) AP-1 (1) Apoptosis (2) Bcl-2 Family (1) Biochemical Assay Reagents (3) BMI1 (1) CDK (1) Drug Derivative (2) Endogenous Metabolite (2) ERK (1) GLUT (1) HDAC (1) Histone Demethylase (1) Histone Methyltransferase (1) IFNAR (1) MDM-2/p53 (1) PI3K (1) Reactive Oxygen Species (ROS) (3) Small Interfering RNA (siRNA) (5) Virus Protease (1)
By Research Areas:	Cancer (7) Endocrinology (2) Infection (2) Inflammation/Immunology (1) Metabolic Disease (3) Neurological Disease (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (2) Human Pre-designed siRNA Sets (1) siRNAs (4)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-119344

MS37452 1 Publications Verification	Histone Methyltransferase	Cancer
MS37452 is a potent inhibitor of CBX7 chromodomain binding to H3K27me3, with a K_d of 27.7 μM. MS37452 can derepress transcription of polycomb repressive complex target gene p16/CDKN2A by displacing CBX7 binding to the INK4A/ARF locus in prostate cancer cells .

HY-P1109

*[Ala92]-p16* (84-103)**	CDK	Cancer
[Ala92]-p16 (84-103) is a peptide derived from the p16CDKN2/INK4a (p16) tumor suppressor protein. [Ala92]-p16 (84-103) binds to both cdk4 and cdk6 and inhibits cdk4-cyclin D1 kinase activity in vitro (IC₅₀: 1.5 μM). [Ala92]-p16 (84-103) blocks cell cycle progression through the G1 phase .

HY-171030

Pro-GA	Reactive Oxygen Species (ROS)	Cancer
Pro-GA is a γ-glutamyl cyclotransferase (GGCT) inhibitor. Pro-GA inhibits the enzymatic activity of GGCT, disrupts glutathione homeostasis, induces the production of mitochondrial ROS, and upregulates the expression of p21, p27 and *p16* in cells. Pro-GA inhibits the growth of cancer cells, induces cell cycle arrest and cellular senescence. Pro-GA exerts anti-tumor effects in breast cancer xenograft mouse models. Pro-GA can be used in research related to bladder cancer and breast cancer .

HY-N0857

Deoxyandrographolide 1 Publications Verification	GLUT HDAC Virus Protease PI3K AMPK Akt Histone Demethylase MDM-2/p53 IFNAR Reactive Oxygen Species (ROS)	Infection Metabolic Disease Inflammation/Immunology
Deoxyandrographolide is an orally active lactone found in the Andrographis paniculata Nees. Deoxyandrographolide shows a K_D of 38.4 μM of HDAC1. Deoxyandrographolide enhances GLUT4 plasma membrane translocation, activates PI3K and AMPK-dependent signaling pathways, suppresses fasting blood glucose, serum insulin, triglycerides, and LDL-cholesterol levels. Deoxyandrographolide enhances HDAC1 expression via inhibited ubiquitination degradation, represses H3K4me3, improves chromosome stability, and restrains aging biomarkers *p16, p21, γH2A.X, p53* and ROS production. Deoxyandrographolide interacts with Foot-and-Mouth Disease Virus 3Cpro active site, inhibits protease and IFN-antagonist activity, derepresses ISG expression, and inhibits viral replication. Deoxyandrographolide can be used for the researches of type 2 diabetes mellitus, vascular senescence and virus infection .

HY-169265

BRD-K20733377	Bcl-2 Family	Others
BRD-K20733377 is an inhibitor for Bcl-2, and exhibits selective cytotoxicity against senescent cells, that inhibits the viability of Etoposide (HY-13629)-induced IMR-90 senescent cell with an IC₅₀ of 10.7 μM. BRD-K20733377 reduces the mRNA expression of aging-related genes p16, p21 and KI67 in aged mouse model .

HY-165997

1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC PC-(P16:0/16:0)	Drug Derivative	Metabolic Disease
1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC is an ester product.

HY-N11604

1-(1(Z)-Hexadecenyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine C16(Plasm)-16:1-PC; PC(P-16:0/16:1); PlsC 16:0/16:1	Biochemical Assay Reagents	Metabolic Disease
1-(1(Z)-Hexadecenyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine [PC (P-16:0/16:1 (9Z))] is a phosphatidylcholine that can be utilized for liposome preparation and serves as a marker in metabolomics research .

HY-168895

c-Fos-IN-1	AP-1 ERK Apoptosis	Cancer
c-Fos-IN-1 (Compound P16) is a c-Jun inhibitor, and decreases mRNA levels and protein levels of c-Fos. c-Fos-IN-1 also inhibits the phosphorylation activity of ERK and the transcriptional activity of AP-1. c-Fos-IN-1 shows anticancer activity by inhibiting ERK/c-Fos/Jun pathway. c-Fos-IN-1 inhibits the proliferation and migration of gastric cancer cells (IC₅₀: 2.31 μM for MGC-803 cell). c-Fos-IN-1 arrests cell cycle at G2/M phase and induces cancer cell apoptosis. c-Fos-IN-1 inhibits gastric cancer tumor growth .

HY-N0992

1,6,7-Trihydroxyxanthone	BMI1 Apoptosis	Cancer
1,6,7-Trihydroxyxanthone is a potent anticancer agent. 1,6,7-Trihydroxyxanthone inhibits cell proliferation and induces cell Apoptosis. 1,6,7-Trihydroxyxanthone decreases Bmi-1 expressio and increases the protein levels expression of P14, P16 .

HY-165157

1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC 16:0p/20:4-PC; PC(P-16:0/20:4); C16(plasm)-20:4-PC	Biochemical Assay Reagents	Others
1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC is a biochemical reagent.

HY-RS16296

H3P10 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
H3P10 Human Pre-designed siRNA Set A contains three designed siRNAs for H3P10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3P10 Human Pre-designed siRNA Set A H3P10 Human Pre-designed siRNA Set A

HY-RS18681

Rbm14 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Rbm14 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rbm14 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Rbm14 Mouse Pre-designed siRNA Set A Rbm14 Mouse Pre-designed siRNA Set A

HY-152922

1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine C16(plasm)-18:2-PC; 1-1(Z)-Hexadecenyl-2-Linoleoyl-sn-glycero-3-PC; PC(P-16:0/18:2)	Biochemical Assay Reagents	Others
1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine (C16(plasm)-18:2-PC; 1-1(Z)-Hexadecenyl-2-Linoleoyl-sn-glycero-3-PC; PC(P-16:0/18:2)) is a phosphatidylcholine, which can be used in lipid preparations and as a marker in metabolomic research .

HY-RS23159

Cdkn2a Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Cdkn2a Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdkn2a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cdkn2a Rat Pre-designed siRNA Set A Cdkn2a Rat Pre-designed siRNA Set A

HY-RS16723

Cdkn2a Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Cdkn2a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdkn2a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cdkn2a Mouse Pre-designed siRNA Set A Cdkn2a Mouse Pre-designed siRNA Set A

HY-RS02414

CDKN2A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CDKN2A Human Pre-designed siRNA Set A contains three designed siRNAs for CDKN2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CDKN2A Human Pre-designed siRNA Set A CDKN2A Human Pre-designed siRNA Set A

HY-N7241

Saudin	Others	Endocrinology
Saudin, derived from Clutia lanceolata, is a hypoglycemic compound that significantly enhances glucose-triggered insulin release from murine pancreatic islets. It belongs to a group of new diterpenoids with a distinct tetracyclic core, suggesting potential as a therapeutic agent for diabetes treatment. Proposed biosynthetic pathways outline alternative cyclization routes from a common precursor, with Lanceolide P (16) identified as a promising lead compound for further development in managing diabetes .

HY-177978

*LysoPE(P-16:0/0:0)*	Endogenous Metabolite	Infection
LysoPE(P-16:0/0:0) is a lysophosphatidylethanolamine and metabolite. LysoPE(P-16:0/0:0) is significantly decreased in the plasma of spinal tuberculosis. LysoPE(P-16:0/0:0) can be screened as potential diagnostic biomarkers for spinal tuberculosis .

HY-185128

*PE(P-16:0/18:2(9Z,12Z))* PlsEtn 16:0/18:2	Endogenous Metabolite	Neurological Disease Endocrinology
PE (P-16:0/18:2(9Z,12Z)) (PlsEtn 16:0/18:2) is a phosphatidylethanolamine that can be used as a metabolic biomarker for evaluating uterine muscle layer infiltration and Alzheimer's disease .

HY-N11605

PC 16:0/18:1 PC(P-16:0/18:1(9Z))

HY-148965A

PtdIns-(3)-P1 (1,2-dipalmitoyl) ammonium DPPI-3-P ammonium; PIP[3'](16:0/16:0) ammonium; PI(3)P (16:0/16:0) ammonium	Drug Derivative Reactive Oxygen Species (ROS)	Others
PtdIns-(3)-P1 (1,2-dipalmitoyl) (Compound 7) ammonium is a derivative of phosphatidylinositol 3-phosphate (PtdIns(3)P). phosphatidylinositol 3-phosphate can bind to the FYVE domain of human EEA1 and act as a second messenger in cellular signaling and membrane trafficking. phosphatidylinositol 3-phosphate can stimulate ROS formation by regulating the neutrophil oxidase complex .

Cat. No.	Product Name

HY-L077

Anti-Pancreatic Cancer Compound Library	4,096 compounds
Pancreatic cancer is a devastating disease with a low overall survival rate. Chemotherapy is the most common treatment for patients presenting with advanced pancreatic cancer. More recently, the era of targeted therapies has generated a lot of interest in discovering better approaches for patients with pancreatic cancer. Commonly mutated genes in pancreatic cancer include K-ras (in 74-100% of cases), p16INK4a (up to 98%), p53 (43 to 76%), DPC4 (about 50%), HER-2/neu (in about 65%) and FHIT (found in 70% of cases). Other genes involved are notch1, Akt-2, BRCA2 and COX-2. These proteins are important targets of target therapies for pancreatic cancer. MCE offers a unique collection of 4,096 compounds with identified and potential anti- pancreatic cancer activity. These compounds target K-Ras, p53, HER2, Notch, AKT, etc. MCE anti-pancreatic cancer compound library is a useful tool for anti-pancreatic cancer drugs screening and other related research.

Anti-Pancreatic Cancer Compound Library

4,096 compounds

Pancreatic cancer is a devastating disease with a low overall survival rate. Chemotherapy is the most common treatment for patients presenting with advanced pancreatic cancer. More recently, the era of targeted therapies has generated a lot of interest in discovering better approaches for patients with pancreatic cancer. Commonly mutated genes in pancreatic cancer include K-ras (in 74-100% of cases), p16INK4a (up to 98%), p53 (43 to 76%), DPC4 (about 50%), HER-2/neu (in about 65%) and FHIT (found in 70% of cases). Other genes involved are notch1, Akt-2, BRCA2 and COX-2. These proteins are important targets of target therapies for pancreatic cancer.

MCE offers a unique collection of 4,096 compounds with identified and potential anti- pancreatic cancer activity. These compounds target K-Ras, p53, HER2, Notch, AKT, etc. MCE anti-pancreatic cancer compound library is a useful tool for anti-pancreatic cancer drugs screening and other related research.

Cat. No.	Product Name	Target	Research Area

HY-P1109

*[Ala92]-p16* (84-103)**	CDK	Cancer
[Ala92]-p16 (84-103) is a peptide derived from the p16CDKN2/INK4a (p16) tumor suppressor protein. [Ala92]-p16 (84-103) binds to both cdk4 and cdk6 and inhibits cdk4-cyclin D1 kinase activity in vitro (IC₅₀: 1.5 μM). [Ala92]-p16 (84-103) blocks cell cycle progression through the G1 phase .

HY-P3602

C3 Peptide P16	Peptides	Cancer
C3 Peptide P16, is a 16 amino acid synthetic peptide derived from human C3d, a fragment generated in trypsin-cleaved C3. C3 Peptide P16 enhances in vitro phosphorylation of pp105 and pp100, a cellular component presenting in the human B lymphoma cells .

HY-P10324

TAT-p16 P16^INK4a peptide	Peptides	Cancer
TAT-p16 (p16INK4a peptide) is a peptide mimic of p16INK4a that can induce an early G phase cell cycle arrest in the absence of active cyclin E:Cdk2 complex .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0857

Deoxyandrographolide 1 Publications Verification	Structural Classification Acanthaceae Simsia foetida (Cav.) S.F.Blake Terpenoids Diterpenoids Plants Source Classification	GLUT HDAC Virus Protease PI3K AMPK Akt Histone Demethylase MDM-2/p53 IFNAR Reactive Oxygen Species (ROS)
Deoxyandrographolide is an orally active lactone found in the Andrographis paniculata Nees. Deoxyandrographolide shows a K_D of 38.4 μM of HDAC1. Deoxyandrographolide enhances GLUT4 plasma membrane translocation, activates PI3K and AMPK-dependent signaling pathways, suppresses fasting blood glucose, serum insulin, triglycerides, and LDL-cholesterol levels. Deoxyandrographolide enhances HDAC1 expression via inhibited ubiquitination degradation, represses H3K4me3, improves chromosome stability, and restrains aging biomarkers *p16, p21, γH2A.X, p53* and ROS production. Deoxyandrographolide interacts with Foot-and-Mouth Disease Virus 3Cpro active site, inhibits protease and IFN-antagonist activity, derepresses ISG expression, and inhibits viral replication. Deoxyandrographolide can be used for the researches of type 2 diabetes mellitus, vascular senescence and virus infection .

HY-N11604

1-(1(Z)-Hexadecenyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine C16(Plasm)-16:1-PC; PC(P-16:0/16:1); PlsC 16:0/16:1	Structural Classification Animals Lipid Source Classification	Biochemical Assay Reagents
1-(1(Z)-Hexadecenyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine [PC (P-16:0/16:1 (9Z))] is a phosphatidylcholine that can be utilized for liposome preparation and serves as a marker in metabolomics research .

HY-N0992

1,6,7-Trihydroxyxanthone	Natural Products Goodyera oblongifolia Raf. Orchidaceae Plants Source Classification	BMI1 Apoptosis
1,6,7-Trihydroxyxanthone is a potent anticancer agent. 1,6,7-Trihydroxyxanthone inhibits cell proliferation and induces cell Apoptosis. 1,6,7-Trihydroxyxanthone decreases Bmi-1 expressio and increases the protein levels expression of P14, P16 .

HY-N7241

Saudin	Clutia lanceolata Forssk. Other Monoterpenes Terpenoids Euphorbiaceae Plants Source Classification	Others
Saudin, derived from Clutia lanceolata, is a hypoglycemic compound that significantly enhances glucose-triggered insulin release from murine pancreatic islets. It belongs to a group of new diterpenoids with a distinct tetracyclic core, suggesting potential as a therapeutic agent for diabetes treatment. Proposed biosynthetic pathways outline alternative cyclization routes from a common precursor, with Lanceolide P (16) identified as a promising lead compound for further development in managing diabetes .

HY-N11605

PC 16:0/18:1 PC(P-16:0/18:1(9Z))	Structural Classification Natural Products Animals Source Classification

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P72785

	CDKN2A Protein, Human Cyclin-dependent kinase inhibitor 2A; CDK4I; MTS-1; P16INK4A	Human	E. coli
	CDKN2A Protein, a potent negative regulator of cell proliferation, forms strong interactions with CDK4 and CDK6, hindering their association with cyclins D and retinoblastoma protein phosphorylation. Acting in a heterodimeric manner, predominantly with CDK6, CDKN2A inhibits cyclin D-CDK4 kinase activity and interacts with ISCO2, contributing to its cell cycle regulatory role. CDKN2A Protein, Human is the recombinant human-derived CDKN2A protein, expressed by E. coli , with tag free.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-P10324

TAT-p16
TAT-p16 (p16INK4a peptide) is a peptide mimic of p16INK4a that can induce an early G phase cell cycle arrest in the absence of active cyclin E:Cdk2 complex .

Host:	Mouse (6) Rabbit (6)
Reactivity:	Human (11) mouse (1) Rat (3) Mouse (5)
Application:	IHC-P (8) ICC/IF (2) IP (5) WB (10) FC (4) ELISA (5)
Isotype:	IgG (6) IgG1 (4) IgG2a (1) IgG2b (1)
Conjugation:	Non-conjugated (12)
Clonality:	Monoclonal (7) Monoclonal Antibody (1) Recombinant (4)
Modification:	Unmodified (9)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P82109

	p16 ARC Antibody (YA1854) P16 Arc; ARPC5; ARC16; Arp2/3 protein complex subunit P16	WB, IHC-P, IP	Human, Mouse, Rat
	p16 ARC Antibody (YA1854) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to p16 ARC.

HY-P82109A

	p16 ARC Antibody (YA1854)(PBS only) P16 Arc; ARPC5; ARC16; Arp2/3 protein complex subunit P16	WB, IHC-P, IP	Human, Mouse, Rat
	p16 ARC Antibody (YA1854) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to p16 ARC.

HY-P80992

	*CDKN2A/p16INK4a Antibody (YA3494)* ARF antibody; CDK4 inhibitor P16 INK4 antibody; CDK4I antibody; CDKN2 antibody; CDKN2A antibody; Cell cycle negative regulator beta antibody; CMM2 antibody; INK4 antibody; INK4a antibody; Melanoma P16 inhibits CDK4 antibody; MLM antibody; MTS1 antibody; Multiple tumor suppressor 1 antibody; P16 antibody; P16 INK4a antibody; P16INK4a antibody; p19 antibody; P19ARF antibody; TP16 antibody;	WB, IHC-P	Human
	CDKN2A/p16INK4a Antibody (YA3494) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P86438

	*CDKN2A/p16INK4a Antibody (YA6130)* 1 Publications Verification Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; P16-INK4a; P16-INK4; P16INK4A; P16;	WB, ICC/IF, IP, ELISA	Human, Mouse, Rat
	CDKN2A/p16INK4a Antibody (YA6130) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P85830

	*CDKN2A/p16INK4a Antibody (YA5522)* Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; P16-INK4a; P16-INK4; P16INK4A; P16;	IHC-P, WB, ICC/IF, ELISA	Human
	CDKN2A/p16INK4a Antibody (YA5522) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P84321

	*CDKN2A/p16INK4a Antibody (YA4018)* ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A	WB, IHC-P, FC, ELISA	Human
	CDKN2A/p16INK4a Antibody (YA4018) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P84321A

	*CDKN2A/p16INK4a Antibody (YA4018)(PBS only)* ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A	WB, IHC-P, FC, ELISA	Human
	CDKN2A/p16INK4a Antibody (YA4018) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P80615

	*CDKN2A/p16INK4a Antibody (YA508)* 1 Publications Verification CDK4 inhibitor P16 INK4 antibody; CDK4I antibody; CDKN2 antibody; CDKN2A antibody; Cell cycle negative regulator beta antibody; CMM2 antibody; Cyclin dependent kinase 4 inhibitor A antibody; Cyclin dependent kinase inhibitor 2A (melanoma P16 inhibits CDK4) antibody; Cyclin Dependent Kinase Inhibitor 2A antibody; Cyclin dependent kinase inhibitor 2A isoform 4 antibody; Cyclin dependent kinase inhibitor 2A isoforms 1/2/3 antibody; Cyclin dependent kinase inhibitor P16 antibody; INK4 antibody; INK4A antibody; MLM antibody; MTS1 antibody; Multiple tumor suppressor 1 antibody; p14 antibody; P16 antibody; P16INK4 antibody; P16INK4a antibody; p19 antibody; p19Arf antibody; TP16 antibody;	WB, IP	Human, Mouse
	CDKN2A/p16INK4a Antibody (YA508) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P80615A

	*CDKN2A/p16INK4a Antibody (YA508)(PBS only)* CDK4 inhibitor P16 INK4 antibody; CDK4I antibody; CDKN2 antibody; CDKN2A antibody; Cell cycle negative regulator beta antibody; CMM2 antibody; Cyclin dependent kinase 4 inhibitor A antibody; Cyclin dependent kinase inhibitor 2A (melanoma P16 inhibits CDK4) antibody; Cyclin Dependent Kinase Inhibitor 2A antibody; Cyclin dependent kinase inhibitor 2A isoform 4 antibody; Cyclin dependent kinase inhibitor 2A isoforms 1/2/3 antibody; Cyclin dependent kinase inhibitor P16 antibody; INK4 antibody; INK4A antibody; MLM antibody; MTS1 antibody; Multiple tumor suppressor 1 antibody; p14 antibody; P16 antibody; P16INK4 antibody; P16INK4a antibody; p19 antibody; p19Arf antibody; TP16 antibody;	WB, IP	Human, Mouse
	CDKN2A/p16INK4a Antibody (YA508)(PBS only) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CDKN2A/p16INK4a.

HY-P88881

	CDKN2A/p14ARF Antibody (YA8565) ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4	IHC-P, FC	Human
	CDKN2A/p14ARF Antibody (YA8565) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CDKN2A/p14ARF.

HY-P88881A

	CDKN2A/p14ARF Antibody (YA8565)(PBS only) ARF; CDK4I; CDKN2; CMM2; INK4; INK4A; MLM; MTS-1; MTS1; P14; P14ARF; P16; P16-INK4A; P16INK4	IHC-P, FC	Human
	CDKN2A/p14ARF Antibody (YA8565) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CDKN2A/p14ARF.

HY-P89810

	*CDKN2A/p16* Antibody (YA9154)**	WB, ELISA	mouse
	CDKN2A/p16 Antibody (YA9154) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to CDKN2A/p16.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-RS18681

Rbm14 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Rbm14 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rbm14 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS23159

Cdkn2a Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Cdkn2a Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdkn2a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS16723

Cdkn2a Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Cdkn2a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdkn2a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS02414

CDKN2A Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
CDKN2A Human Pre-designed siRNA Set A contains three designed siRNAs for CDKN2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Screening Libraries

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides